Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Hodgkin Lymphoma, North American Practice

Joseph Connors

MD

🏢BC Cancer Vancouver🌐Canada

Medical Oncologist and Clinical Professor

72
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Joseph Connors is a preeminent Canadian expert in Hodgkin lymphoma who has contributed to establishing ABVD as a standard treatment in North America. He led key studies examining PET-interim response to guide ABVD continuation or escalation in early and advanced Hodgkin lymphoma. His research has also evaluated brentuximab vedotin in relapsed/refractory settings and as a frontline combination. He has published extensively on long-term survival, late effects, and treatment sequencing in Hodgkin lymphoma.

Share:

🧪Research Fields 研究领域

ABVD treatment Hodgkin
Hodgkin early stage treatment
brentuximab vedotin relapse
Stanford V Hodgkin
Hodgkin long-term outcomes

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 Joseph Connors 的研究动态

Follow Joseph Connors's research updates

留下邮箱,当我们发布与 Joseph Connors(BC Cancer Vancouver)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment